Hidradenitis Suppurative (HS) Treatment Market is projected to reach US$ 1,240.9 million by 2033
The global hidradenitis suppurativa (HS) treatment market is expected to surpass an impressive valuation of US$ 763.6 million in 2023 and is projected to reach US$ 1,240.9 million by 2033, growing at a CAGR of 4.97%. Hidradenitis suppurativa market is currently having vast pipeline therapies targeting interleukins,...
Source: pharmiweb.com